Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency
Anna Roppelt, Ulyana Markina, Irina Beloglazova, Vasily Parshin, Dmitry Kanner, Dmitry Pershin, Mariia Fadeeva, Elena Raykina, Maxim Aleksenko, Alexander Karaulov, Mariana Lysenko, Daria Fomina · 2025
Read Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency by Anna Roppelt, Ulyana Markina, Irina Beloglazova, Vasily Parshin, Dmitry Kanner, Dmitry Pershin, Mariia Fadeeva, Elena Raykina, Maxim Aleksenko, Alexander Karaulov, Mariana Lysenko, Daria Fomina (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11825476.txt.
Description
Anna Roppelt and eleven co-authors report a case, published in 2024, of a man whose immune system had lost a key brake. A fault in one gene leaves a signal path stuck on, which drives lung disease, low blood counts, and swollen glands. The man, aged thirty-two, had lived on steroid drugs for decades, with the harms that long use brings.
Once the gene fault was named, the team switched him to a drug that blocks the stuck path at its source. Scant past data back that move, but the logic of the fault points straight at it. The report gives his course on the new drug. Such cases build the proof base for a rare fault, one patient at a time, and may free others from lifelong steroids.
Catalog record
| CREATOR | Anna Roppelt, Ulyana Markina, Irina Beloglazova, Vasily Parshin, Dmitry Kanner, Dmitry Pershin, Mariia Fadeeva, Elena Raykina, Maxim Aleksenko, Alexander Karaulov, Mariana Lysenko, Daria Fomina |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |